16 Apr 2024 | 03:00 PM GMT

Big Tech and Pharma: Will they, won't they?

Participants:

Sophie Ghazal Director of Strategy, Health FuturesMicrosoft
Sophie Ghazal
Director of Strategy, Health FuturesMicrosoft
Jo Peddhinti AdvisoryHLTH Community
Jo Peddhinti
AdvisoryHLTH Community
Alex Gilbert VP Life SciencesAmalgamRx
Alex Gilbert
VP Life SciencesAmalgamRx
Arun Bhatia Commercial Strategy Lead - Digital HealthAstellas Pharma Rx+ Business Accelerator
Arun Bhatia
Commercial Strategy Lead - Digital HealthAstellas Pharma Rx+ Business Accelerator
Cédric Odje InvestorDebiopharm Innovation Fund SA
Cédric Odje
InvestorDebiopharm Innovation Fund SA
Hannes Toivanen Lead, Global Digital Ecosystems EngamentsTakeda
Hannes Toivanen
Lead, Global Digital Ecosystems EngamentsTakeda
Laura Pasternak Chief of Staff, VenturesTakeda Pharmaceuticals
Laura Pasternak
Chief of Staff, VenturesTakeda Pharmaceuticals
Louise O'Mahony Head of Customer SuccessEXi
Louise O'Mahony
Head of Customer SuccessEXi
Michael Kremliovsky Executive Director, Medical Devices & eHealthBayer Pharmaceuticals
Michael Kremliovsky
Executive Director, Medical Devices & eHealthBayer Pharmaceuticals
Mike Pace Founder & CEOPalmHealthCo
Mike Pace
Founder & CEOPalmHealthCo
Susanne Gruber Strategic Healthcare AdvisorIgnited Vision
Susanne Gruber
Strategic Healthcare AdvisorIgnited Vision
Thibault Demoures Business Development OfficerHealthAnea
Thibault Demoures
Business Development OfficerHealthAnea
Zina Manji Founder/Principal, Regulatory StrategistInnopathwayz, LLC
Zina Manji
Founder/Principal, Regulatory StrategistInnopathwayz, LLC

About this Meeting

As Big Tech seeks to expand their footprint in the health industry, the dynamics of their relationship with Pharma are under scrutiny.


The increasing needs within the healthcare sector to effectively manage the growing volume of data, coupled with shifts in care delivery models, offer a significant opportunity for these Tech giants, experts in advanced analytics and consumerism.

While the potential collaboration between Big Tech and Pharma holds promise for driving innovation across the pharma value chain, their potential for disruption creates pressing questions for Pharma, as they navigate this new and dynamic landscape. 

Join this meeting to discuss:  


  • How are Big Tech engaging with pharma and how can collaborative efforts drive innovation in healthcare?

  • Where might Big Tech pose the greatest challenge, and how might Pharma mitigate disruption?

  • In a collaboration, how can Pharma ensure data will be utilized responsibly to balance innovation with privacy concerns?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.